ArticleClinical epigenetics2020

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.

Manon Lernoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.